GlobeNewswire
Register
Sign In
English
Français
Contact Us
Global Distribution
Newswire Services
Regulatory Filings
Media Partners
About this file
EquelsHEBBioReactor.jpg
Format
JPEG
Source
AIM ImmunoTech Inc.
Downloads
Original
Large
Medium
Small
ASSOCIATED PRESS RELEASE
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan Designation by the European Medicines Agency for Alferon N Injection to Treat Patients With Middle East Respiratory Syndrome (MERS)
Published
October 19, 2015 08:30 ET
Ok